Mandate

Vinge has advised Lendify in connection with a bond issue

February 07, 2018 Banking and Finance

Lendify AB (”Lendify”), a P2P-lending plattform, has issued bonds in the amount of SEK 400,000,000 on 29 January 2018 through its wholly-owned subsidiary Lendify Sweden 2 AB (publ).

The bonds have a tenor of two years and an annual interest rate of three-months Stibor + 4.5%. The bonds are backed by a portfolio of promissory notes issued by consumers in Sweden in favour of Lendify.

Together with the management of the company, Carnegie Investment Bank and DNB Markets as arrangers and their legal advisor, Vinge acted for Lendify in the structuring and documentation of the transaction.

Vinge’s team consisted of Albert Wållgren, Lionardo Ojeda and Sebastian Frisk.

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024